Table 3 Overview of the demographic and clinical dataset
From: King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
Basics | Sample Size | 1796 |
Patients Consented | 549 | |
Number of variables | 13 | |
Involvement in clinical trial | Yes /No | |
Demographics | Demographics | Age at diagnosis Ethnicity Postcode |
Prostate Cancer Characteristics | Diagnostic markers | PSA Gleason score TNM stage |
Treatment | Treatment type | Surgery, Active monitoring, Anti-cancer drug regimen (hormone therapy), Anti-cancer drug regimen (cytotoxic chemotherapy), Brachytherapy, Specialist palliative care |
Comorbidities | All, Previous/other cancers, Cardiovascular disease, HIV or infectious disease, Hyperlipidaemia and hypercholesterolemia, Diabetes, Psychological | |
Medication | Total number of medications, Erectile dysfunction medication | |
Outcome | Disease stable, Discharged to GP, Treatment discharged to GP, Discharged to different hospital, Progression, Progression to metastasis, Recurrence, Death, Awaiting treatment, Refused further treatment, Treated privately, Lost to follow up |